FDA Import Refusal AEK-8157767-5/11/1B — APROGEN PHARMACEUTICALS, INC.
The FDA refused shipment AEK-8157767-5/11/1B from APROGEN PHARMACEUTICALS, INC. (South Korea) on Jan 12, 2021. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 27,75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Jan 12, 2021
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VCP99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 27,75